Haemonetics HAE Other accrued liabilities
Other accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Haemonetics's other accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Haemonetics's other accrued liabilities?
- Haemonetics (HAE) reported other accrued liabilities of $158.34M in Q1 2026.
- How has Haemonetics's other accrued liabilities changed year-over-year?
- Haemonetics's other accrued liabilities increased by 6.9% year-over-year, from $148.13M to $158.34M.
- What is the long-term trend for Haemonetics's other accrued liabilities?
- Over 5 years (2021 to 2026), Haemonetics's other accrued liabilities has grown at a 2.7% compound annual growth rate (CAGR), from $138.59M to $158.34M.
- What does other accrued liabilities mean?
- This captures miscellaneous short-term obligations that do not fit into standard categories like accounts payable or accrued compensation. It often includes items such as customer deposits, short-term tax provisions, or other minor contractual liabilities. It provides insight into the breadth of the company's short-term financial commitments.